{"organizations": [], "uuid": "25356cb96c3d0ca70531b2c9db60eca52786410f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180326.html", "section_title": "Archive News &amp; Video for Monday, 26 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-shenzhen-weiguang-biological-produ/brief-shenzhen-weiguang-biological-products-receives-permission-of-clinical-trial-granted-by-china-fda-idUSL3N1R849D", "country": "US", "domain_rank": 408, "title": "BRIEF-Shenzhen Weiguang Biological Products ‍receives permission of clinical trial granted by China FDA", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.002, "site_type": "news", "published": "2018-03-26T19:06:00.000+03:00", "replies_count": 0, "uuid": "25356cb96c3d0ca70531b2c9db60eca52786410f"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-shenzhen-weiguang-biological-produ/brief-shenzhen-weiguang-biological-products-receives-permission-of-clinical-trial-granted-by-china-fda-idUSL3N1R849D", "ord_in_thread": 0, "title": "BRIEF-Shenzhen Weiguang Biological Products ‍receives permission of clinical trial granted by China FDA", "locations": [], "entities": {"persons": [], "locations": [{"name": "china", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "weiguang biological products", "sentiment": "negative"}, {"name": "shenzhen weiguang biological products co ltd", "sentiment": "negative"}, {"name": "beijing headline news", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 26 (Reuters) - Shenzhen Weiguang Biological Products Co Ltd :\n* Says it received permission of clinical trial granted by China FDA with respect to Human coagulation Factor Ⅷ\nSource text in Chinese: goo.gl/nUau5F\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://goo.gl/nUau5F", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-03-26T19:06:00.000+03:00", "crawled": "2018-03-27T12:12:40.015+03:00", "highlightTitle": ""}